Achieve Life Sciences, Inc. (ACHV)
7.84
-0.65
(-7.66%)
USD |
NASDAQ |
Sep 08, 16:00
7.90
+0.06
(+0.77%)
Pre-Market: 08:08
Achieve Life Sciences Max Drawdown (5Y) : 99.57% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 99.57% |
| July 31, 2026 | 99.64% |
| June 30, 2026 | 99.66% |
| May 31, 2026 | 99.69% |
| April 30, 2026 | 99.72% |
| March 31, 2026 | 99.72% |
| February 28, 2026 | 99.72% |
| January 31, 2026 | 99.72% |
| December 31, 2025 | 99.73% |
| November 30, 2025 | 99.75% |
| October 31, 2025 | 99.87% |
| September 30, 2025 | 99.87% |
| August 31, 2025 | 99.89% |
| July 31, 2025 | 99.89% |
| June 30, 2025 | 99.90% |
| May 31, 2025 | 99.90% |
| April 30, 2025 | 99.91% |
| March 31, 2025 | 99.92% |
| February 28, 2025 | 99.94% |
| January 31, 2025 | 99.94% |
| December 31, 2024 | 99.94% |
| November 30, 2024 | 99.94% |
| October 31, 2024 | 99.94% |
| September 30, 2024 | 99.94% |
| August 31, 2024 | 99.94% |
| Date | Value |
|---|---|
| July 31, 2024 | 99.94% |
| June 30, 2024 | 99.94% |
| May 31, 2024 | 99.94% |
| April 30, 2024 | 99.94% |
| March 31, 2024 | 99.94% |
| February 29, 2024 | 99.94% |
| January 31, 2024 | 99.94% |
| December 31, 2023 | 99.94% |
| November 30, 2023 | 99.94% |
| October 31, 2023 | 99.94% |
| September 30, 2023 | 99.94% |
| August 31, 2023 | 99.94% |
| July 31, 2023 | 99.94% |
| June 30, 2023 | 99.94% |
| May 31, 2023 | 99.94% |
| April 30, 2023 | 99.94% |
| March 31, 2023 | 99.94% |
| February 28, 2023 | 99.94% |
| January 31, 2023 | 99.94% |
| December 31, 2022 | 99.94% |
| November 30, 2022 | 99.94% |
| October 31, 2022 | 99.94% |
| September 30, 2022 | 99.94% |
| August 31, 2022 | 99.94% |
| July 31, 2022 | 99.94% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Anika Therapeutics, Inc. | 83.15% |
| Perspective Therapeutics, Inc. | 93.08% |
| MiMedx Group, Inc. | 85.36% |
| ProText Mobility, Inc. | 96.45% |
| ABVC BioPharma, Inc. | 99.79% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -25.10 |
| Beta (5Y) | 2.247 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 83.62% |
| Historical Sharpe Ratio (5Y) | -0.0565 |
| Historical Sortino (5Y) | -0.1313 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.15% |